İçeriğe geç
akaturk Akademik ölçüm

OpenAlex konusu

Circular RNAs in diseases

Bu sayfa OpenAlex konu etiketine göre çalışmaları ve o konuda görünen akademisyenleri listeler. YÖKSİS temel alan / yan dal değildir.

OpenAlex 1.142 eser 40 yazar konusu

Çalışmalar

1.142 eser

  1. Circulating miR-107, miR-199, and miR-485 Have High Diagnostic Potential in Non-small Cell Lung Cancer: An Exploratory Study 2026

    Background: Non-small cell lung cancer (NSCLC) accounts for the majority of lung cancer cases. Circulating microRNAs (miRNAs) have emerged as promising non-invasive biomarkers for cancer detection. In this exploratory study, we investigated the diagnostic and prognostic value of four circulating miRNAs (miR-107, miR-1…

  2. MicroRNAs in immune-related diseases: mechanism, functions and therapeutic perspectives 2026

    MicroRNAs (miRNAs) are evolutionarily conserved, non-coding RNA molecules approximately 18–25 nucleotides in length that regulate gene expression at the post-transcriptional level. Their principal mechanism of action is post-transcriptional gene silencing via RNA interference, achieved by binding to complementary sequ…

  3. Effect of miR-105-5p on Cell Proliferation, Colony Formation, and hTERT/P53/P21 Gene Expression in Multiple Cancer Cell Lines 2026

    Aim: MicroRNAs are small endogenous RNA molecules that do not code for proteins but have the capacity to influence cancer development by promoting or inhibiting it. They play normal biological roles in regulating cell metabolism, development, apoptosis, and metastasis. While numerous studies on the functional mechanis…

  4. Figure 2 from MicroRNA-146a Protects against Hepatocellular Carcinoma through Suppression of CCL5 2026

    Examples of lesions in DEN-treated WT and miR-146a−/− female mouse livers. A and B, Focus of cytologic alteration (FCA). At 10× (A), the lesion appears as a small (less than 2 mm) zone of more darkly staining hepatocytes. At 40×, nonlesional hepatocytes at the periphery of the lesion (top) appear larger than cells wit…

  5. Clinical significance and expression profile of DNA repair-associated miR-34c-5p and miR-1246 in prostate malignancy 2026

    Özet henüz yok.

  6. MicroRNA-21 Emerges as Key Prognostic Indicator After Breast Cancer Surgery 2026

    Background/Objective: MicroRNA-21 (miR-21) is one of the most widely studied oncogenic microRNAs and has been implicated in breast cancer progression, therapy resistance, and metastatic potential. However, its utility as a long-term prognostic biomarker in patients undergoing mastectomy remains insufficiently clarifie…

  7. Association of miR-34a with metastatic progression through the FoxO3a–SIRT1 regulatory axis in breast cancer 2026

    Background/aim: Breast cancer represents the foremost cause of cancer-related mortality among women worldwide and is characterized by a markedly high metastatic potential, contributing substantially to its clinical severity and poor prognosis. This study aimed to evaluate the interrelationship among silent information…

  8. MicroRNA-299-3p as a potential marker of tumor size in non-small cell lung cancer 2026

    Background: Lung cancer is one of the world's leading causes of cancer-related death. A tumor biopsy is the gold standard for diagnosis but may not be representative of the whole tumor. We therefore need non-invasive biomarkers to guide us in structure, mass, prognosis and treatment. Therefore, alternative non-invasiv…

  9. Resveratrol Modulates lncRNA Expression Profiles in Leukemia Stem Cell Line 2026

    Objective: Leukemia stem cells (LSCs) are central to therapy resistance and disease relapse. Long non-coding RNAs (lncRNAs) act as key epigenetic regulators whose dysregulation sustains leukemic stemness. This study aimed to evaluate whether resveratrol, a natural polyphenol, can selectively modulate the lncRNA expres…

  10. Serum lncRNA HOTAIRM1, but not miR-182-5p, as a Potential Non-Invasive Biomarker for Endometrial Cancer 2026

    Background: Endometrial cancer (EC) is the second most common gynecological malignancy and remains a major contributor to morbidity and mortality among women worldwide. Current diagnostic and prognostic tools have limited accuracy, highlighting the need for reliable, non-invasive biomarkers. Non-coding RNAs (ncRNAs),…

  11. Small Non-Coding RNA in Breast Cancer Therapy: Yin-Yang 2026

    Breast cancer continues to be a significant worldwide issue. Systemic chemotherapy remains the mainstay of breast cancer therapy despite advancements in technology. However, their side effects and the decreased patient quality of life hinder long-term therapeutic success. Personalized treatment is more crucial for bre…

  12. Cardiovascular Dysfunction in Type 2 Diabetes: The Role of MicroRNAs 2026

    Özet henüz yok.

Akademisyenler

40 akademisyen